6 Results for "

6-keto-PGF1α

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "6-keto-PGF1α" in MCE Product Catalog:

Cat. No.: HY-111097
CAS No.: 924636-93-1
AF3442 is a potent and selective mPGES-1 inhibitor (IC50 = 0.06 μM) which reduces monocyte PGE2 generation also in the presence of plasma proteins. AF3442 shows selectivity over other prostanoids (TXB2, PGF and 6-keto-PGF). AF3442 can be used for research in analgesia .
loading...
    loading...
Cat. No.: HY-118652
CAS No.: 68324-95-8
Synonyms: ω-3 6-keto PGF
Research Areas:  

Metabolic Disease

Δ17-6-keto Prostaglandin F1α (Δ17-6-keto PGF1α) is a cyclooxygenase (COX) product of eicosapentaenoic acid (EPA) in various tissues such as seminal vesicles, lung, Polymorphonuclear leukocytes, and ocular tissues. Δ17-6-keto PGF1α and other 3-series COX products from EPA, such as PGF3α, PGE3, and thromboxane B3, may be involved in the reduced incidence of glaucoma in patients on a marine-rich (EPA-rich) diet.
loading...
    loading...
Cat. No.: HY-133941
CAS No.: 64700-71-6
Synonyms: 2,3-Dinor-6-keto-PGF
2,3-Dinor-6-keto-prostaglandin F1α (2,3-Dinor-6-keto-PGF1α) is the major urinary metabolite of Prostaglandin I2 (HY-A0126A). 2,3-Dinor-6-keto-prostaglandin F1α is applicable to the research of coronary heart disease .
loading...
    loading...
Cat. No.: HY-105142
CAS No.: 76604-64-3
Target:  

COX

Research Areas:  

Inflammation/Immunology

M-5011 is a potent and orally active anti-inflammatory agent. M-5011 shows potent antinociceptive effects and inhibits kaolin (HY-W115786)-induced writhing. M-5011 decreases peritoneal 6-keto-PGF1 alpha levels with low ulcerogenic activities. M-5011 shows anti-inflammatory and anti-pyretic effects and analgesic effect .
loading...
    loading...
Cat. No.: HY-W009640
CAS No.: 2210-63-1
Target:  

Drug Derivative COX

Research Areas:  

Inflammation/Immunology

Mofebutazone is a pyrazolidinedione non-steroidal anti-inflammatory agent (NSAID). Mofebutazone exhibits weak COX inhibition, no effect on LOX, and slightly suppresses the percentage of leukocyte phagocytosis in vitro. Mofebutazone can be used in research related to soft tissue rheumatism .
loading...
    loading...
Cat. No.: HY-W009640A
CAS No.: 41468-34-2
Target:  

Drug Derivative COX

Research Areas:  

Inflammation/Immunology

Mofebutazone sodium is a pyrazolidinedione non-steroidal anti-inflammatory agent (NSAID). Mofebutazone sodium exhibits weak COX inhibition, no effect on LOX, and slightly suppresses the percentage of leukocyte phagocytosis in vitro. Mofebutazone sodium can be used in research related to soft tissue rheumatism .
loading...
    loading...